For people suffering from pollen-sensitive allergic rhinitis, springtime often proves to be a particularly challenging period, marked by incessant runny noses and bouts of sneezing. The problem is the persistence of these symptoms, which can last for weeks or even months. In such cases, nasal irriga
Senior doctors, who complained of "burnout" and vowed to work only 52 hours a week to prevent patient safety incidents due to striking junior doctors, have not been able to reduce their workload in reality.That’s because when they reduce their treatment by curtailing working hours, the hospital's “i
Vivozon Group, comprising Vivozon and Vivozon Pharmaceutical, has joined forces with Boryung to commercialize Vivozon's domestically developed non-narcotic painkiller, opiranserin (VVZ-149), in Korea.The partnership was formalized through a memorandum of understanding (MOU) signed on Wednesday, whic
Samsung Bioepis said it domestically released Epysqli (ingredient: eculizumab), a biosimilar referencing Soliris, at a much lower price than the original, on Monday. Soliris, developed by Alexion Pharmaceuticals and marketed by AstraZeneca, is used for treating rare conditions such as paroxysmal noc
A clue has been found to predict the onset of neurodegenerative diseases that have been a challenge in treating REM sleep behavior disorder.Korean researchers have developed a machine learning model to predict dementia and Parkinson's disease using the “brain waves” of REM sleep behavior disorder pa
AITRICS and Korea University Anam Hospital (KUAH) have signed a memorandum of understanding to advance medical AI technology.AITRICS is renowned for its expertise in biometric signal-based medical AI technology. Its flagship AI solution, AITRICS-VC, is designed to predict deteriorations in patient c
Kukje Pharma said Tuesday that it has signed a strategic marketing partnership contract with Celltrion for the domestic sales of Celltrion's CT-P42 (aflibercept), an Eylea biosimilar, for treating ophthalmic retinal diseases.Under the agreement, Celltrion will exclusively provide Kukje Pharma with d
Gencurix, NGeneBio's largest shareholder, has sold some of its shares to 10 people, including NGeneBio CEO Choi Dae-chul, drawing attention to its background.As a result of the stock transfer, the largest shareholder of NGeneBio has changed to KT, Korea's second-largest wireless carrier, which found
Coreline Soft said its artificial intelligence (AI)-powered coronary artery calcification automatic diagnostic solution, AVIEW CAC, has received 510(k) clearance from the U.S. FDA.A 510(k) is a premarket submission made to the FDA to demonstrate that the device to be marketed is as safe and effectiv
AbbVie Korea said the Korean health insurance coverage for Rinvoq (upadacitinib), a once-daily, oral, selective and reversible JAK1 inhibitor, has been expanded to treat moderately to severely active ulcerative colitis and Crohn's disease in adults, effective from April 1. Rinvoq is covered by healt
Influenza is an acute respiratory illness caused by a virus that can lead to complications in the respiratory system, including pneumonia, and major organ systems, including neurological complications, and in severe cases, death. It causes increased morbidity and mortality, especially in high-risk g
Yuyu Pharma said its urinary disorder treatment Yuhylyx Soft Capsule (dutasteride) has won approval from the food and drug administration of the Philippines and Myanmar and has completed product registration.These are expected to boost the company's exports to the Southeast Asian pharmaceutical mark
Pfizer Korea and Hanlim MS are strengthening their partnership to co-market immunology disease treatments.Pfizer Korea said Tuesday that the company has signed an agreement with Hanlim MS to co-market Enbrel (etanercept), the first anti-tumor necrosis factor (TNF)-α inhibitor approved for treating r
On Monday, President Yoon Suk Yeol came forward to explain his plan to increase the medical school enrollment quota by 2,000 and persuade resigned trainee doctors to return to teaching hospitals.In conclusion, however, medical sources said Yoon’s 50-minute speech hardened the junior doctors’ determi
Hanmi Pharm, a Korean pharmaceutical giant, said on Tuesday that it submitted an investigational new drug (IND) application to the U.S. FDA on March 29 for its next-generation GLP-1/GIP/GCG triple-agonist, named HM15275, to initiate a phase 1 clinical trial targeting obesity.The trial will assess th
Daewoong Pharmaceutical said it signed a strategic partnership with Chong Kun Dang Pharm. to co-market Fexuclue (ingredient: Fexuprazan), the 34th domestically developed new drug in Korea and a treatment for gastroesophageal reflux disease (GERD).With the signing of the cooperation agreement, the tw
Ybrain, a local mental health therapeutics company, entered into a strategic partnership with Friend & Companion, a specialized MSO (Management Service Organization) and CRO (Clinical Research Organization) company, to co-market its proprietary electroencephalogram diagnostic device, MINDD SCAN.MIND
Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate-to-severe plaque psoriasis in adults, receives health insurance benefits in Korea for treating adult patients with chronic severe plaque psoriasis.The first TYK2 inhibitor and once-daily oral treatment approved for modera
oncoMASTER, a Korean cancer precision medicine company, said it has been designated as a member of Nvidia's startup incubation program Inception.oncoMASTER is a subsidiary of Korea University Medical Technology Holdings and was established based on the achievements of the K-Master Project Corps, whi
Orion, a Korean confectionary company, has become the largest shareholder of antibody-drug conjugate (ADC) drug developer LigaChem Biosciences (formerly LegoChem Biosciences) by paying all of its stock purchase prices.On March 29, Orion announced that it has completed the payment of 548.5 billion wo